A várandósok gyógyszerés vé doszerkezelése: A jelenlegi hazai gyakorlat kritikája az újabb bizonyítékok alapján

Translated title of the contribution: Risks and benefits of medication in pregnant women

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The Hungarian Case-Control Surveillance System of Congenital Abnormalities can provide appropriate data for the evaluation of risk and benefits of drugs and pregnancy supplements in pregnant women. Among the main principles, the importance of time factor (the first trimester concept is outdated) and the explanation of frequent false teratogenic findings (e.g. recall bias, chance effect, etc.) are discussed. The main conclusion is that at present the exaggerated teratogenic risk of drugs is much more harmful for the fetus than the rare teratogenic effect of some drugs themselves. Medical doctors and other experts therefore need more education to know the principles and findings of modern human teratology because it may help us to have a better balance between the risks and benefits of drug use during pregnancy. On the other hand, the primary prevention of neural-tube defects and some other congenital abnormalities is demonstrated by periconceptional folic acid or folic acid-containing multivitamin supplementation. Unfortunately, this new method is used rarely and inappropriately (due to the late onset of supplementation) in Hungary.

Original languageHungarian
Pages (from-to)544-553
Number of pages10
JournalLege Artis Medicinae
Volume14
Issue number8-9
Publication statusPublished - Sep 1 2004

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this